Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franzese

Showing results (761-770 of 943) with videos related to

Pageof 95
Sort By:
Radiation Oncology (London, England)|June 3, 2016
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resectionPierina Navarria, Federico Pessina, Luca Cozzi, et al.
Organic Letters|June 12, 2018
Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl FluoridesParamita Mukherjee, Cristian P Woroch, Leah Cleary, et al.
Biomed Research International|November 29, 2013
Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatmentGiovanni L Gravina, Gravina Giovanni Luca, Claudio Festuccia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 23, 2023
Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgeryBruna Bolzan, Giovanni Morani, Vanni Rizzati, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysisLetizia Ferella, Erika Limoncin, Francesca Vittorini, et al.
Anticancer Research|March 2, 2018
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term OutcomesMaurizio Valeriani, Pierluigi Bonfili, Chiara Reverberi, et al.
Diabetologia|May 24, 2022
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune diseaseSara Bruzzaniti, Erica Piemonte, Enza Mozzillo, et al.
Oncology Letters|December 15, 2018
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practiceAlessio Cortellini, Valentina Cocciolone, Azzurra Irelli, et al.
ACS Nano|February 4, 2014
Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructureDiogo Mosqueira, Stefania Pagliari, Koichiro Uto, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at RiskCiro Franzese, Stefano Tomatis, Sofia Paola Bianchi, et al.
Pageof 95

Showing results (761-770 of 943) with videos related to

Sort By:
Pageof 95
Radiation Oncology (London, England)|June 3, 2016
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resectionPierina Navarria, Federico Pessina, Luca Cozzi, et al.
Organic Letters|June 12, 2018
Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl FluoridesParamita Mukherjee, Cristian P Woroch, Leah Cleary, et al.
Biomed Research International|November 29, 2013
Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatmentGiovanni L Gravina, Gravina Giovanni Luca, Claudio Festuccia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 23, 2023
Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgeryBruna Bolzan, Giovanni Morani, Vanni Rizzati, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysisLetizia Ferella, Erika Limoncin, Francesca Vittorini, et al.
Anticancer Research|March 2, 2018
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term OutcomesMaurizio Valeriani, Pierluigi Bonfili, Chiara Reverberi, et al.
Diabetologia|May 24, 2022
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune diseaseSara Bruzzaniti, Erica Piemonte, Enza Mozzillo, et al.
Oncology Letters|December 15, 2018
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practiceAlessio Cortellini, Valentina Cocciolone, Azzurra Irelli, et al.
ACS Nano|February 4, 2014
Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructureDiogo Mosqueira, Stefania Pagliari, Koichiro Uto, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at RiskCiro Franzese, Stefano Tomatis, Sofia Paola Bianchi, et al.
Pageof 95